Using microarray and Northern blot analyses, Johns Hopkins University researchers discovered that the levels of almost all miRNAs increases following cell-cell contact in Drosophila and mammalian cell lines, regardless of whether these cells display contact inhibition.
The University of Maryland, Baltimore is now participating in Horizon's "Targeting Cancer Consortium," in which the company supplies its gene-engineering platform to academic researchers, who create cellular disease models that Horizon in-licenses and sells to drug makers.
The GPPC aims to "get the conversation going" about the best way to implement the resource. The HHS Secretary’s Advisory Committee for Genetics, Health, and Society last year recommended creating the registry, but the GPPC said it was short on details about how to do so.
Some in the clinical genetics community believe the rise of DTC testing offers a prime opportunity to raise awareness of genetics among the general population, despite skepticism about using the tests for clinical decision-making.
Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.
NHLBI in late January put out an RFP for the program, which calls for researchers to develop proteomics technologies and apply them to solve clinical puzzles. It is set to begin early next year, shortly after its current two major proteomics initiatives expire.
DNAPrint, Laboratory Corporation of America, Duke University, Lab21, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Diseases and Stroke, and more …